All members have the option of attending our various HTC-centric events which include:
Date: Thursday, March 20th, 2025
Time: 2:00pm – 3:00pm ET
TITLE:
Takeda FVIII Portfolio
OBJECTIVE:
Please join Takeda leadership to review Takeda FVIII Products & Resources Available.
INTENDED AUDIENCE:
All HTC staff
SPEAKER:
Anthea Cherednichenko, VP US Hematology Franchise Head
Anthea leads the sales and marketing teams for Takeda’s Hematology portfolio. Anthea previously served as the General Manager for Takeda Austria. Prior to that role, she was in Global and European leadership roles in Hematology based out of Switzerland. Originally from Australia, Anthea spent her early career years in medical device and health IT marketing roles in both Australia and Asia, before joining Baxter (later acquired by Takeda) in 2013. Anthea holds a Master of Public Health from the University of Sidney and Master of Business Administration from Victoria University.
